BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  IntuitiveX Welcomes Desney Tan as Senior Advisor and Chief Technologist to its Seattle-Based Life Science Consultancy

  IntuitiveX, Seattle-based Life Science Consultancy, welcomes Dr. Desney Tan, General Manager of Microsoft Healthcare, as its Senior Advisor and Chief Technologist

  September 24, 2019

   · 

  2 min read
• Biotech Beach

  nRichDX Introduces High-Yield Sample Prep for Liquid Biopsies

  nRichDX Inc. announces the launch of its RevolutionTM System, a high-yield sample prep platform.

  September 24, 2019

   · 

  2 min read
• Business

  AllianceRx Walgreens Prime earns specialty pharmacy reaccreditation from ACHC

  AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the U.S., proudly announces it has received reaccreditation from the Accreditation Commission for Health Care (ACHC) for its specialty pharmacy services.

  September 24, 2019

   · 

  1 min read
• Policy

  AHF: WHO Continues to Fail in Ebola Response

  AHF Echoes MSF Call on WHO for Increased Ebola Vaccine in DRC, Greater Transparency

  September 24, 2019

   · 

  3 min read
• Pharm Country

  UroGen Investor Day Details Positive Clinical Updates, UGN-101 Launch Preparedness, and Pipeline Advances

  UroGen Pharma Ltd. (Nasdaq: URGN), a clinical-stage biopharmaceutical company developing treatments to address unmet needs in the field of urology, today presented updates on its advancing pipeline for urologic cancers and UGN-101 launch readiness at its Investor Day in New York on September 24, 2019.

  September 24, 2019

   · 

  8 min read
• Pharm Country

  Lannett Announces Offering of $75 million of Convertible Senior Notes Due 2026

  Lannett Company, Inc. (NYSE: LCI) today announced that it intends to offer, subject to market conditions and other factors, $75 million aggregate principal amount of convertible senior notes due 2026

  September 24, 2019

   · 

  4 min read
• Business

  Natural Alternatives International, Inc. Announces Fiscal Year 2019 and Q4 Results

  Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today reported financial operating results for the fourth quarter and fiscal year ended June 30, 2019.

  September 24, 2019

   · 

  10 min read
• Policy

  eHealth Calls Projected Medicare Advantage Premium Reductions a “Big Win” for Beneficiaries Ahead of Medicare Annual Enrollment Period

  Projected increased enrollment in Medicare Advantage may also be good news for brokers like eHealth

  September 24, 2019

   · 

  2 min read
• Business

  Two Northwestern Medicine Physicians Receive Awards from The North American Menopause Society

  Dr. Lauren Streicher and Dr. Traci Kurtzer recognized for outstanding contributions to the field of women’s health and menopause

  September 24, 2019

   · 

  4 min read
• Business

  Medicenna Strengthens Board of Directors by Appointment of Seasoned Biopharma Executive Ms. Karen Dawes

  A total of 36.15% of the issued and outstanding common shares of the Company were represented in person and by proxy at the Meeting.

  September 24, 2019

   · 

  6 min read